{"id": "1344939927872520192", "creation": 1609493641.0, "user_id": "1044812038462197761", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 3, "quote_count": 0}}, "text": "[#COVID19 | #vaccine]\n\u2757Safety and immunogenicity of #INO4800 DNA #vaccine against #SARSCoV2: A preliminary report of an open-label, Phase 1 clinical trial\n#INOVIO | The Lancet\nhttps://t.co/CCUc91s76v https://t.co/FVBPljBfTX", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#INO4800", "#VACCINE", "#SARSCOV2", "#INOVIO"]}